Intermittent altitude exposures reduce acute mountain sickness at 4300 m.
Beidleman BA, Muza SR, Fulco CS, Cymerman A, Ditzler D, Stulz D, Staab JE, Skrinar GS, Lewis SF, Sawka MN.
Beidleman BA, et al. Among authors: muza sr.
Clin Sci (Lond). 2004 Mar;106(3):321-8. doi: 10.1042/CS20030161.
Clin Sci (Lond). 2004.
PMID: 14561214
Clinical Trial.